Triethylene Glycol

Triethylene Glycol

SCHEMBL170477

Cc1cc(C(C)(C(=O)O)c2cc(C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O.OCCOCCOCCO

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
GLRA3 O75311 1/20 0.37
GLRB P48167 1/20 0.37
GSR P00390 2/20 0.35
GABBR2 O75899 1/20 0.35
GABBR1 Q9UBS5 1/20 0.35
VCAM1 P19320 6/20 0.34
ALDH1A1 P00352 2/20 0.34
POLB P06746 2/20 0.34
CA2 P00918 1/20 0.34
TYR P14679 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
GPR55 Q9Y2T6 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SCN2A Q99250 2/20 0.33
NR5A2 O00482 1/20 0.33
NR5A1 Q13285 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Di(Hydroxyethyl)Ether SCHEMBL3683440 0.92 GSR (0.42) CYP1A2CYP2C9CYP2C19GLRA3GLRB
SCHEMBL29695404 0.87 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19GLRA3GLRB
SCHEMBL170476 0.87 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19GLRA3GLRB
SCHEMBL17181577 0.87 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19GLRA3GLRB
SCHEMBL29416252 0.87 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19GLRA3GLRB
SCHEMBL462695 0.85 CYP2C9 (0.55) CYP1A2CYP2C9CYP2C19GLRA3GLRB
Water SCHEMBL18093526 0.84 CYP2C9 (0.53) CYP1A2CYP2C9CYP2C19GLRA3GLRB
SCHEMBL808674 0.81 CYP2C19 (0.37) CYP1A2CYP2C9CYP2C19GLRA3GLRB
Ethylene Glycol SCHEMBL7080497 0.81 GSR (0.47) CYP1A2CYP2C9CYP2C19GLRA3GLRB
SCHEMBL2474150 0.81 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19GLRA3GLRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 528 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236100-A1 POLYMER STRUCTURE AND APPLICATIONS THEREOF CHITEC TECHNOLOGY CO., LTD. (TW) 2025-07-24 US claimed
EP-4506416-A1 THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PREPARING THERMOPLASTIC RESIN COMPOSITION AND USE OF PLASTIC FILM Chimei Corporation (TW) 2025-02-12 EP claimed
US-20250043129-A1 THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PREPARING THERMOPLASTIC RESIN COMPOSITION AND USE OF PLASTIC FILM CHIMEI CORPORATION (TW) 2025-02-06 US claimed
EP-4090710-B1 COATING COMPOSITIONS GKN AEROSPACE SERVICES LTD (GB) 2025-01-01 EP claimed
EP-4407008-A1 ANTI-FOG COATING AND PREPARATION METHOD THEREFOR, AND ANTI-FOG GLASS Fuyao Glass Industry Group Co., Ltd. (CN) 2024-07-31 EP claimed
EP-3632950-B1 STORAGE-STABLE HEAT-CURABLE HYBRID EPOXY FUNCTIONAL COMPOSITION AND TRANSPARENT HEAT-CURED COATINGS PREPARED THEREFROM ESSILOR INT (FR) 2024-07-17 EP claimed
US-20240191007-A1 SURFACE GRADIENT CROSS-LINKING METHOD OF ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE AND THE APPLICATION THEREOF B ONE MEDICAL SUZHOU CO LTD (CN) 2024-06-13 US claimed
US-20240174839-A1 STABILIZER MIXTURE BASF SE (DE) 2024-05-30 US claimed
US-11952439-B2 Surface gradient cross-linking method of ultra-high molecular weight polyethylene and the application thereof b-ONE Medical (Suzhou) Co., Ltd. (CN) 2024-04-09 US claimed
US-20240010836-A1 POLYAMIDE PARTS WITH LOW FUEL PERMEATION EMS-CHEMIE AG (CH) 2024-01-11 US claimed
EP-3124541-A1 FLUOROPOLYMER COMPOSITION FOR MOBILE ELECTRONIC DEVICE Solvay Specialty Polymers Italy S.p.A. (IT) 2017-02-01 EP claimed
EP-2927263-B1 Polyamide moulding compositions, in particular for manufacturing moulded parts in the drinking water sector EMS PATENT AG (CH) 2016-03-09 EP claimed
US-20150274935-A1 POLYAMIDE MOULDING COMPOSITION, IN PARTICULAR FOR THE PRODUCTION OF MOULDINGS IN THE DRINKING WATER SECTOR EMS-PATENT AG (CH) 2015-10-01 US claimed
US-20150218374-A1 POLYAMIDE MOULDING COMPOUNDS WITH FLAME-RETARDANT PROPERTIES AND VERY GOOD LONG-TERM HEAT-AGEING RESISTANCE EMS-PATENT AG (CH) 2015-08-06 US claimed
US-8829087-B2 Transparent layer forming polymer PROMERUS, LLC (US) 2014-09-09 US claimed
US-20110224335-A1 INK COMPOSITION AND METHOD OF FABRICATING LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME KIM SUNG-HEE 2011-09-15 US claimed
US-7935552-B2 Ink composition and method of fabricating liquid crystal display device using the same LG DISPLAY CO., LTD. (KR) 2011-05-03 US claimed
US-20100120181-A1 INK COMPOSITION AND METHOD OF FABRICATING LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2010-05-13 US claimed
US-20090176936-A1 Ink composition and method of forming a pattern using the same LG DISPLAY CO., LTD. (KR) 2009-07-09 US claimed
EP-0114028-B1 COLOUR-PHOTOGRAPHIC RECORDING MATERIAL CIBA-GEIGY AG (CH) 1988-08-03 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240191007-A1 SURFACE GRADIENT CROSS-LINKING METHOD OF ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE AND THE APPLICATION THEREOF RPL7, PLAUR, CUTA CYP1A2 1213/4885CYP2C9 963/4885CYP2C19 990/4885
US-11952439-B2 Surface gradient cross-linking method of ultra-high molecular weight polyethylene and the application thereof RPL7, PLAUR, CUTA CYP1A2 1213/4885CYP2C9 963/4885CYP2C19 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.